AI Opportunities in Pharma with Eli Lilly, AstraZeneca, & Bristol Myers Squibb | Technovation 880

Few industries are as knowledge-centric as pharma and healthcare, where groundbreaking innovations can positively impact lives and potentially eradicate diseases. In this episode of Technovation, we feature a discussion from our May 2024 Metis Strategy Digital Symposium, where AstraZeneca CDO/CIO Cindy Hoots, Bristol Myers Squibb CDTO Greg Meyers, and Eli Lilly CIDO Diogo Rau explore the profound impact of artificial intelligence on talent management, research and development, and operational efficiencies within the pharma industry. These executives delve into the innovative applications of AI, from improving clinical trials and document generation to enhancing internal workflows and customer service. Discover how these AI pioneers are laying the foundation for a future where AI and human ingenuity drive unprecedented advancements in medicine and patient care. 00:00 Introduction 01:46 Greg Meyers on AI Integration 04:15 Cindy Hoots on AI Foundations 07:24 Diogo Rau on AI in Clinical Trials 09:53 Diogo Rau on AI Adoption Challenges 12:43 Greg Meyers on Generative AI in Drug Development 16:05 Cindy Hoots on AI Research Assistant 20:08 Greg Meyers on AI for Customer and Employee Interaction 26:53 Conclusion and Final Poll An audio-only version of this interview is available as episode 880 of Metis Strategy’s podcast, #Technovation with Peter High. Learn more at http://bit.ly/Technovation-880. Subscribe to Technovation on your podcast platform of choice: https://link.chtbl.com/Technovation To learn more, visit https://www.metisstrategy.com/technovation-podcast/ Connect with us on social LinkedIn: https://www.linkedin.com/company/metis-strategy/ Twitter/X: https://twitter.com/MetisStrategy ---------------- #podcast #pharma